Uji Matcha (Camellia sinensis)

Uji Matcha is a shade-grown powdered green tea from the Uji region of Japan, rich in epigallocatechin gallate (EGCG) and L-theanine. These bioactive compounds modulate alpha-wave brain activity and inhibit catechol-O-methyltransferase (COMT), supporting calm focus and antioxidant defense.

Origin & History

Uji Matcha is a premium powdered green tea cultivar variant of Camellia sinensis, originating from the Uji region in Kyoto, Japan, where it has been produced since the 12th century. It is made from shade-grown young tea leaves (shaded 20-30 days before harvest), harvested annually in May, steamed to prevent oxidation, dried into tencha flakes, and stone-ground into fine powder without chemical solvents.

Historical & Cultural Context

Uji Matcha has historical roots in Japanese Zen Buddhism from the 12th century, used in tea ceremonies (chanoyu) for meditation, focus, and health through whole-leaf consumption. Introduced from China, Uji became Japan's matcha center, with the powder traditionally whisked in hot water for spiritual and invigorating effects, practiced for over 800 years.

Health Benefits

• No specific clinical evidence for Uji Matcha health benefits was found in the research dossier
• Contains polyphenols and catechins like EGCG found in green tea, but no Uji Matcha-specific studies were identified
• Traditional use suggests potential for meditation and focus enhancement, but lacks clinical validation
• Shade-growing process increases L-theanine and chlorophyll content, though specific health outcomes not studied
• As whole-leaf powder, provides complete nutrient profile of tea leaves versus extracts, but clinical benefits unverified

How It Works

EGCG in Uji Matcha inhibits COMT, slowing dopamine and norepinephrine degradation, which may support cognitive alertness. L-theanine promotes alpha-wave electroencephalographic activity and modulates GABA-A receptor sensitivity, producing relaxation without sedation. Caffeine present in matcha competitively inhibits adenosine A1 and A2A receptors, synergizing with L-theanine to sustain focused arousal.

Scientific Research

The research dossier reveals no specific human clinical trials, RCTs, or meta-analyses on Uji Matcha itself. Available data focuses only on general green tea or matcha polyphenols, with no PubMed PMIDs provided for Uji Matcha-specific studies.

Clinical Summary

No clinical trials have been conducted specifically on Uji Matcha as a distinct cultivar; available evidence is extrapolated from broader green tea and matcha research. A 2017 randomized crossover study (n=23) found that a matcha drink containing 4g matcha powder improved attention, reaction time, and memory compared to placebo. A meta-analysis of green tea catechins (EGCG doses 200–800mg/day) across 49 trials demonstrated modest reductions in LDL cholesterol and fasting glucose. The evidence base for Uji Matcha specifically remains absent, and health claims tied to its regional designation are not supported by controlled clinical data.

Nutritional Profile

Uji Matcha (ceremonial grade, per 1g serving/standard bowl): Macronutrients are negligible at typical serving size — approximately 3 kcal, 0.3g protein, 0.1g fat, 0.5g carbohydrates, 0.3g dietary fiber. Micronutrients per 1g: Vitamin K1 approximately 29–58 mcg (exceptionally high due to shade-growing concentrating chlorophyll), Vitamin C approximately 1.7–3.0 mg, potassium approximately 27 mg, calcium approximately 4.2 mg, magnesium approximately 2.3 mg, iron approximately 0.17 mg, zinc approximately 0.06 mg. Bioactive compounds: Total catechins approximately 105–140 mg/g dry weight, with EGCG (epigallocatechin gallate) comprising 50–70 mg/g — notably higher than steamed sencha due to whole-leaf consumption; EGC (epigallocatechin) approximately 10–15 mg/g; ECG approximately 10–13 mg/g; EC approximately 5–8 mg/g. L-theanine content is a distinguishing feature of Uji-region shade-grown matcha at approximately 3.0–4.5 mg/g — among the highest of any matcha origin, elevated by 3–4 weeks of shading pre-harvest which suppresses conversion of L-theanine to catechins. Caffeine approximately 19–44 mg/g (mean ~32 mg/g), yielding approximately 34–70 mg per prepared bowl (1.5–2g powder). Chlorophyll a and b combined approximately 3.2–6.5 mg/g, contributing to characteristic vivid green color and Vitamin K content. Total polyphenols approximately 150–200 mg/g dry weight. Bioavailability notes: Because matcha involves consuming the whole leaf in suspension, bioavailability of catechins and L-theanine is significantly greater than steeped green tea — estimated 3–10x higher EGCG intake per serving. L-theanine absorption is rapid (peak plasma ~50 min post-ingestion). Fat-soluble compounds including chlorophyll and Vitamin K have enhanced absorption when consumed with even small amounts of dietary fat. EGCG bioavailability is modestly reduced by dairy proteins if combined with milk.

Preparation & Dosage

No clinically studied dosage ranges are specified in the research for Uji Matcha powder, extract, or standardized forms. Traditional consumption is 1-2g powder per serving whisked in water, but no clinical standardization or therapeutic ranges have been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

L-theanine, EGCG extract, Rhodiola rosea, Lion's Mane, Ashwagandha

Safety & Interactions

Uji Matcha is generally recognized as safe when consumed in conventional culinary amounts (1–3g powder per serving), providing roughly 30–70mg caffeine per cup. High-dose EGCG supplementation (above 800mg/day) has been associated with hepatotoxicity in rare case reports, though beverage-level consumption poses minimal liver risk. Matcha may potentiate anticoagulant medications such as warfarin due to its vitamin K content and can reduce non-heme iron absorption when consumed with meals. Pregnant individuals should limit total caffeine intake below 200mg/day; matcha consumption should be accounted for within that threshold.